21 results
Thumbnail

D3.295 - Comparing Real-World and AI-Enabled Market Research in Caregivers of Individuals with Peanut Allergy

Thumbnail

D3.296 - Alpha-gal Syndrome with Concomitant Milk Sensitization in a Patient with Asthma and Allergic Rhinitis: A Case Report

Thumbnail

D3.297 - De-labelling peanut allergy in a 19-year-old woman with detectable Ara h 2 sensitization: a real-life, exercise-augmented oral food challenge

Thumbnail

D3.298 - The Good, the Bad and the Ugly : Mugwort, Mango, and Pineapple

Thumbnail

D3.300 - Wheat tolerance induction protocol

Thumbnail

D3.301 - Аллергия на белки коровьего молока у детей: сосредоточено на короткоцепочечных жирных кислотах

Thumbnail

D3.302 - Sesame as an under-recognized allergen: storage protein sensitization underlying food-induced anaphylaxis in a young adult

Thumbnail

D3.303 - Buckwheat Allergy in Bologna Metropolitan Area: Often Severe, Often Hidden

Thumbnail

D3.304 - Real-Life Evaluation of the Egg Ladder in a Tertiary Pediatric Allergy Center in Turkey

Thumbnail

D3.305 - Isolated IgE-Mediated Anaphylaxis to Pine Nut in an adult

Thumbnail

D1.437 - A Decade of Research on Janus Kinase Inhibitors in Atopic Dermatitis: A Global Bibliometric Analysis (2015–2024)

Thumbnail

D1.438 - Dupilumab for Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: Real-Life Assessment of Efficacy and Safety

Thumbnail

D1.442 - Design and Preclinical Development of a Bispecific Antibody Targeting IL11 and TL1A

Thumbnail

D1.443 - Preclinical Development of a Dual LIGHT/TL1A Bispecific Antibody

Thumbnail

D1.446 - Lebrikizumab in patients with urticarial vasculitis - a case series

Thumbnail

D1.447 - Comparison of Disease Duration, Remission, and Other Disease-Related Parameters with the Duration of Omalizumab Treatment in Patients with Chronic Spontaneous Urticaria

Thumbnail

D1.448 - Long-Term Efficacy and Stability of Lebrikizumab in Treating Face/Head and Neck Involvement in Patients with Moderate-to-Severe Atopic Dermatitis

Thumbnail

D1.449 - A Phase 2, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Briquilimab in Adults with Chronic Urticaria (Trial in Progress)

Thumbnail

D1.439 - Urticaria Voices: Physician-reported perspectives of chronic urticaria care and its treatment in China (UV in China)

Thumbnail

D1.441 - A Bispecific Antibody Targeting IL13 and IL31 for the Treatment of Inflammatory Skin Diseases